These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 27238871)
21. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. Prakash O; Teng S; Ali M; Zhu X; Coleman R; Dabdoub RA; Chambers R; Aw TY; Flores SC; Joshi BH Arch Biochem Biophys; 1997 Jul; 343(2):173-80. PubMed ID: 9224727 [TBL] [Abstract][Full Text] [Related]
23. Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde. Kaminskas LM; Pyke SM; Burcham PC Org Biomol Chem; 2004 Sep; 2(18):2578-84. PubMed ID: 15351821 [TBL] [Abstract][Full Text] [Related]
24. Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cells. Chitnis S; Mondal D; Agrawal KC Life Sci; 2002 Jul; 71(8):967-78. PubMed ID: 12084393 [TBL] [Abstract][Full Text] [Related]
25. Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Szabados E; Fischer GM; Toth K; Csete B; Nemeti B; Trombitas K; Habon T; Endrei D; Sumegi B Free Radic Biol Med; 1999 Feb; 26(3-4):309-17. PubMed ID: 9895221 [TBL] [Abstract][Full Text] [Related]
26. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of beta-globin gene expression by 3'-azido-3'-deoxythymidine in human erythroid progenitor cells. Spiga MG; Weidner DA; Trentesaux C; LeBoeuf RD; Sommadossi JP Antiviral Res; 1999 Dec; 44(3):167-77. PubMed ID: 10651068 [TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger. Meng Q; Su T; O'Neill JP; Walker VE Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380 [TBL] [Abstract][Full Text] [Related]
29. Genotoxicity of 3'-azido-3'-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Sussman HE; Olivero OA; Meng Q; Pietras SM; Poirier MC; O'Neill JP; Finette BA; Bauer MJ; Walker VE Mutat Res; 1999 Oct; 429(2):249-59. PubMed ID: 10526209 [TBL] [Abstract][Full Text] [Related]
30. Comparative metabolism of the antiviral dimer 3'-azido-3'-deoxythymidine-P-2',3'-dideoxyinosine and the monomers zidovudine and didanosine by rat, monkey, and human hepatocytes. Pan-Zhou XR; Cretton-Scott E; Zhou XJ; Xie MY; Rahmani R; Schinazi RF; Duchin K; Sommadossi JP Antimicrob Agents Chemother; 1997 Nov; 41(11):2502-10. PubMed ID: 9371357 [TBL] [Abstract][Full Text] [Related]
31. Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3'-azido-2',3'-dideoxythymidine. Agarwal RP; Olivero OA Mutat Res; 1997 May; 390(3):223-31. PubMed ID: 9186571 [TBL] [Abstract][Full Text] [Related]
32. Induction of Fas receptor and Fas ligand by nodularin is mediated by NF-κB in HepG2 cells. Feng G; Li Y; Bai Y Toxicol Appl Pharmacol; 2011 Mar; 251(3):245-52. PubMed ID: 21262250 [TBL] [Abstract][Full Text] [Related]
33. Effects of zidovudine (AZT) and dideoxyinosine (ddI) on human trophoblast cells. Plessinger MA; Miller RK Reprod Toxicol; 1999; 13(6):537-46. PubMed ID: 10613402 [TBL] [Abstract][Full Text] [Related]
34. The potential toxicological insights about the anti-HIV drug azidothymidine-derived monoselenides in human leukocytes: Toxicological insights of new selenium-azidothymidine analogs. Mariano D; de Souza D; Meinerz DF; Allebrandt J; de Bem AF; Hassan W; Rodrigues O; da Rocha J Hum Exp Toxicol; 2017 Sep; 36(9):910-918. PubMed ID: 27777322 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-1β enhances FasL-induced caspase-3/-7 activity without increasing apoptosis in primary mouse hepatocytes. Lutz A; Sanwald J; Thomas M; Feuer R; Sawodny O; Ederer M; Borner C; Humar M; Merfort I PLoS One; 2014; 9(12):e115603. PubMed ID: 25551609 [TBL] [Abstract][Full Text] [Related]
36. Toxicology and Carcinogenesis Studies of Mixtures of 3'-Azido-3'-Deoxythymidine (AZT), Lamivudine (3TC), and Nevirapine (NVP) (CAS Nos. 30516-87-1, 134678-17-4, 129618-40-2) in Genetically Modified C3B6.129F1-Trp53(tm1Brd) N12 Haploinsufficient Mice (in utero and postnatal gavage studies). National Toxicology Program Natl Toxicol Program Genet Modif Model Rep; 2013 Oct; (16):1-236. PubMed ID: 24503698 [TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. McKee EE; Bentley AT; Hatch M; Gingerich J; Susan-Resiga D Cardiovasc Toxicol; 2004; 4(2):155-67. PubMed ID: 15371631 [TBL] [Abstract][Full Text] [Related]
38. Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production. Lewis LD; Amin S; Civin CI; Lietman PS Hum Exp Toxicol; 2004 Apr; 23(4):173-85. PubMed ID: 15171568 [TBL] [Abstract][Full Text] [Related]
39. Zidovudine-induced diaphragmatic contractile dysfunction: impact of an antioxidant diet. Wheeler S; Maxwell-Bawden A; Herb RA; Gallagher GE; Coast JR Respirology; 2005 Mar; 10(2):171-6. PubMed ID: 15823181 [TBL] [Abstract][Full Text] [Related]